Journal of hypertension
-
Journal of hypertension · Jul 2005
Comparative StudyCost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
Evaluate the cost effectiveness of losartan compared with atenolol from a Swedish national health system perspective. ⋯ Based on the results from the LIFE trial, treatment with losartan compared with atenolol, in hypertensive patients with LVH, is a cost-effective intervention.